Amytrx Therapeutics

Nashville, United States

Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies.

$18.0M raised

May 2022

Series A

Biopharma Biotechnology Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Amytrx Therapeutics

How much funding has Amytrx Therapeutics raised?

Amytrx Therapeutics has raised $18.0M in total funding. The most recent round was Series A. The last funding was announced in May 2022.

Where is Amytrx Therapeutics headquartered?

Amytrx Therapeutics is headquartered in Nashville, United States.

What does Amytrx Therapeutics do?

Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies.

What stage is Amytrx Therapeutics at?

Amytrx Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 25, 2022.

MLA

"Amytrx Therapeutics — Funding & Investors." VCBacked, May 25, 2022, https://www.vcbacked.co/company/amytrx-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). Amytrx Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/amytrx-therapeutics

Wikipedia (cite web)

{{cite web |title=Amytrx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/amytrx-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 25, 2022.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.